identifying new opportunities and ultimately creating value for all our stakeholders.” First Quarter Financial Highlights Thermo Fisher reported first quarter revenue was $10.36 billion versus $ ...

Former Thermo Fisher Scientific & PPD Executive Deepens Health Care ... It's a dynamic time in our industry with new therapeutic modalities and digital technologies creating opportunities for ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Thermo Fisher Scientific’s proposal to build a new corporate aircraft hangar and office at Pease in Portsmouth gains approval ...

Thermo Fisher did not immediately respond to Pharmaceutical Technology on whether existing sites would benefit from the investment or whether new facilities would be developed over the coming years.

Raymond James lowered the firm’s price target on Thermo Fisher (TMO) to $525 from $667 and keeps an Outperform rating on the shares. Thermo ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Baird lowered the firm’s price target on Thermo Fisher (TMO) to $573 from $603 and keeps an Outperform rating on the shares. The firm updated ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...